Breaking News
Samsung Biologics to provide CDMO service for Enzolytics mAb therapies
The CDMO will support IND filings for Enzolytics’ anti-HIV and anti-SARS-CoV-2 monoclonal antibodies
Metrics Contract to assist ESSA on oral oncology drug development
“We are excited to partner with ESSA on a program that is ultimately intended to benefit cancer patients. Our focus ...
CN Bio launches oncology service for drug discovery
The service provides a means to explore the relationships between pharmacokinetics, pharmacodynamics (PK/PD) and ...
Glass or polymer? swissfillon and SiO2 collaborate to deliver the best of both worlds in high quality filling
Fill and finish CDMO swissfillon and material science company SiO2 gave a joint presentation at MC Live to explain how ...
PharmaZell and Novasep enter negotiations for new platform
The German and French companies have entered into exclusive negotiations to create a leading European platform in the ...
Catalent to manufacture Phathom gastrointestinal medicine
P-CABs are a class of medicines that block acid secretion in the stomach
Taking a lifecycle approach to fill-finish success
Dr Kevin Robinson recently spoke to swissfillon founder and CEO, Daniel Kehl, and Business Development Director, Carole ...
Single Use Support supplies filling and filtration platform for CGT CDMO
Indianapolis-based Genezen has ordered RoSS.FILL CGT to fill lentiviral vectors into small single-use bags
Cytiva to help implement workflows at Lakes Bioscience facility
The companies say the collaboration will create 250 highly-skilled jobs at the £350m factory
Biologics and specialty medicines: planning your packaging from clinic to launch (part I)
The pharmaceutical landscape continues to evolve with an ever-increasing focus on specialty medicines. As a result, ...
Harnessing the power of HPAPIs: key considerations
Adam Kujath, Senior Director at Sterling Pharma Solutions, discusses the key issues that companies need to consider ...
Decentralised manufacturing: how outsourcing is helping to bring the personalised medicine promise to reality
Personalised medicine represents a revolution in healthcare strategies. Combining traditional clinical information with ...
Genequine selects Exothera to help scale up gene therapy candidate
GQ-303 is the company’s intraarticular gene therapy candidate, which it says turns joint cells into factories for ...
Eurofarma to manufacture Pfizer-BioNTech doses for Latin America
Annual production is planned to exceed 100 million COVID-19 vaccine doses annually and all of these will exclusively be ...
In Brief
Most Popular
Inspiration and Learning
People
- Aslan Pharmaceuticals makes appointments to scientific board
- Nanoform to elect Jeanne Thoma as board member
- CosmoTrace appoints ex-TraceLink VP to lead in North America
- Pfizer announces appointment of Chief Business Innovation Officer
- Rentschler Biopharma appoints Chief Scientific Officer
- Optibrium appoints Prof Andy Black non-executive chair
- Centrient Pharmaceuticals announces Non-Executive Supervisory Board appointment
- Philippe Deecke appointed Chief Financial Officer of Lonza Group
